drugset
drugset / Trial / NCT06548204

Effect and Safety of Fexofenadine Hydrochloride vs Placebo in Patients With Acute Myocardial Infaction: A Randomized Clinical Trial

NCT06548204 ↗

Phase 2 Recruiting 160 enrolled Second Affiliated Hospital, Zhejiang University, School of Medicine
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study was to evaluate the efficacy and safety of fexofenadine hydrochloride on the basis of standard treatment after PCI in STEMI patients.

Timeline

Start
2025-01-20
Primary completion
2026-12-30
Completion
2027-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Fexofenadine Unknown 60 mg —

Indications

ST-elevation myocardial infarction